Sanara MedTech Inc. (SMTI) Reports Q1 Loss, Tops Revenue Estimates

Financial Performance - Sanara MedTech Inc. reported a quarterly loss of $0.41 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.31, and compared to a loss of $0.21 per share a year ago, indicating a significant decline in performance [1] - The company posted revenues of $23.43 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.32%, and showing an increase from year-ago revenues of $18.54 million [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.29 on revenues of $25.35 million, and for the current fiscal year, it is -$1.78 on revenues of $107.2 million [7] - The estimate revisions trend for Sanara MedTech is mixed, leading to a Zacks Rank 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [6] Market Performance - Sanara MedTech shares have increased by approximately 5.7% since the beginning of the year, outperforming the S&P 500, which gained only 0.1% [3] - The outlook for the industry, specifically the Medical - Products sector, is currently in the bottom 31% of over 250 Zacks industries, which may impact the stock's performance [8]